Exploring Three High Growth Tech Stocks in the United Kingdom

In This Article:

In the last week, the United Kingdom market has been flat, but over the past 12 months, it has risen by 6.7%, with earnings forecast to grow by 15% annually. In this context, identifying high growth tech stocks that can capitalize on these favorable conditions is crucial for investors seeking robust returns.

Top 10 High Growth Tech Companies In The United Kingdom

Name

Revenue Growth

Earnings Growth

Growth Rating

STV Group

13.15%

46.78%

★★★★★☆

Gaming Realms

11.57%

22.07%

★★★★★☆

YouGov

14.29%

29.79%

★★★★★☆

Facilities by ADF

52.00%

144.70%

★★★★★☆

Redcentric

4.89%

63.79%

★★★★★☆

Windar Photonics

67.08%

130.82%

★★★★★☆

LungLife AI

100.61%

100.97%

★★★★★☆

IQGeo Group

11.49%

63.61%

★★★★★☆

Beeks Financial Cloud Group

24.63%

57.95%

★★★★★☆

Vinanz

113.60%

125.86%

★★★★★☆

Click here to see the full list of 47 stocks from our UK High Growth Tech and AI Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Craneware

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Craneware plc, with a market cap of £803.93 million, develops, licenses, and supports computer software for the healthcare industry in the United States.

Operations: Craneware plc generates revenue primarily from its healthcare software segment, which reported $189.27 million in sales. The company focuses on developing, licensing, and supporting software solutions tailored for the U.S. healthcare market.

Craneware, a UK-based tech firm, shows robust growth with revenue and earnings projections outpacing the market. Expected to grow revenues by 8.2% annually—faster than the UK's 3.8%—and earnings by an impressive 25.6% per year, it eclipses the broader market's 14.5%. This financial vigor is complemented by strategic moves like recent share buybacks totaling £5 million and active pursuit of acquisitions that align with its expansion goals in the U.S. healthcare sector. Moreover, a partnership with Microsoft enhances its offerings on Azure, integrating advanced AI to drive efficiencies in healthcare operations—a sector where it already impacts nearly 200 million patient encounters through its data insights. This synergy between innovative tech solutions and strategic market positioning underpins Craneware’s potential in transforming healthcare efficiency and profitability. With R&D investments tailored to leverage emerging technologies such as AI within its Trisus platform, Craneware not only secures a competitive edge but also ensures sustainable growth amidst evolving industry demands.